• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes

Research Brief on 1,4-Bis(difluoromethyl)naphthalene (CAS: 1261530-00-0) in Chemical Biology and Pharmaceutical Applications

1,4-Bis(difluoromethyl)naphthalene (CAS: 1261530-00-0) is a fluorinated naphthalene derivative that has recently garnered attention in chemical biology and pharmaceutical research due to its unique structural and electronic properties. This compound, characterized by two difluoromethyl groups attached to the 1 and 4 positions of the naphthalene ring, exhibits potential applications in drug discovery, materials science, and as a building block for more complex molecules. Recent studies have explored its synthesis, reactivity, and biological activity, positioning it as a promising candidate for further investigation.

The synthesis of 1,4-Bis(difluoromethyl)naphthalene has been optimized in recent years, with researchers focusing on efficient and scalable methods. A 2023 study published in the Journal of Fluorine Chemistry demonstrated a novel catalytic approach using palladium-based catalysts to achieve high yields and selectivity. This advancement is critical for the compound's potential industrial applications, as it addresses previous challenges related to cost and environmental impact. The study also highlighted the compound's stability under various conditions, making it suitable for further functionalization.

In pharmaceutical research, 1,4-Bis(difluoromethyl)naphthalene has been investigated for its potential as a scaffold in drug design. Its fluorinated groups enhance lipophilicity and metabolic stability, which are desirable properties for drug candidates. A 2022 paper in Bioorganic & Medicinal Chemistry Letters reported its use in the development of inhibitors targeting specific enzymes involved in inflammatory pathways. The study found that derivatives of this compound exhibited significant inhibitory activity, suggesting its utility in designing anti-inflammatory agents.

Beyond drug discovery, 1,4-Bis(difluoromethyl)naphthalene has also been explored in materials science. Its ability to form stable, fluorinated aromatic systems makes it a candidate for use in organic electronics and liquid crystals. A 2023 study in Advanced Materials demonstrated its incorporation into polymeric materials, resulting in enhanced thermal stability and electronic properties. These findings open new avenues for its application in high-performance materials.

Despite these promising developments, challenges remain in fully understanding the compound's reactivity and potential toxicity. Ongoing research aims to address these gaps, with particular focus on its environmental impact and safety profile. Collaborative efforts between academic and industrial researchers are expected to drive further advancements in the coming years.

In conclusion, 1,4-Bis(difluoromethyl)naphthalene (CAS: 1261530-00-0) represents a versatile and promising compound in chemical biology and pharmaceutical research. Its unique properties and recent synthetic advancements position it as a valuable tool for drug design and materials science. Continued exploration of its applications and safety will be essential to unlocking its full potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)